Phibro Animal Health Corporation
PAHC
$33.26
-$0.20-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.51% | 3.51% | 54.01% | -17.51% | 555.57% |
| Total Depreciation and Amortization | -3.44% | 0.48% | 16.74% | -12.89% | 9.00% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | -71.30% | 248.43% | 13.49% |
| Total Other Non-Cash Items | 67.03% | 20.62% | -45.22% | 708.36% | -88.05% |
| Change in Net Operating Assets | -6.47% | 25.21% | -135.31% | -269.13% | 147.63% |
| Cash from Operations | -16.26% | 108.04% | -56.27% | -50.71% | 1,302.93% |
| Capital Expenditure | -38.02% | 19.62% | -5.05% | -69.66% | 0.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 607.98% | 99.64% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.52% | 15.55% | -1,049.67% | 108.03% | -124.76% |
| Cash from Investing | 2.20% | 18.23% | -198.75% | 61.46% | 92.99% |
| Total Debt Issued | 17.74% | -27.91% | 42.08% | -25.27% | -83.16% |
| Total Debt Repaid | 7.47% | -17.46% | -2.16% | 41.46% | 45.77% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.08% | 0.00% | 0.00% | 0.02% | -0.10% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 87.88% | -216.19% | 310.34% | 75.90% | -111.66% |
| Foreign Exchange rate Adjustments | 597.45% | -540.19% | -91.18% | 102.17% | 116.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.78% | -465.39% | -38.45% | 214.36% | -144.10% |